Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Rigshospitalet, Denmark

Overview

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * De novo autoimmune hepatitis * Consent Exclusion Criteria: * age below 18 * pregnancy

Rigshospitalet, Dept. of Hepatology A-2121

Copenhagen, Denmark

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.